Nigeria has become the first country to receive the new MenFive meningitis vaccine from the Vaccine Alliance-funded global stockpile, with a shipment delivered by UNICEF.
The vaccine, developed through a 13-year collaboration between PATH and Serum Institute of India, protects against the five main serogroups of meningococcal meningitis impacting Africa.
The doses will be used to respond to an ongoing meningococcus C outbreak, targeting around a million children in six local government areas in Jigawa state.
Gavi, the Vaccine Alliance, funds the global stockpiles of vaccines against cholera, Ebola, meningitis, and yellow fever, and supports outbreak response campaigns in lower-income countries.
